German healthcare fraud "running into billions"
This article was originally published in Clinica
Insider knowledge about prescription processing, coupled with criminal intent, costs the health service billions of Marks each year," says Christine Luer, chairperson of the Lower Saxony-based regional office of Germany's largest sickness fund, the AOK. Mrs Luer's comments were made after completion of a three-and-a-half year investigation by the AOK's "false accounting" group. The study used information from some 60 statutory health insurance funds from various German regions, including representatives of the companies', guilds' and agricultural sickness funds.
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.